Samaritan Center

Samaritan Center

Services:
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient

Transitional Services

• Aftercare/continuing care
• Outcome follow-up after discharge
• Discharge Planning
• Naloxone and overdose education

Ancillary Services

• Case management service
• Suicide prevention services
• Mental health services

Education and Counseling Services

• Hepatitis education, counseling, or support
• Individual counseling
• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Marital/couples counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Family counseling

Treatment Approaches

• Substance use disorder counseling
• Telemedicine/telehealth therapy
• Trauma-related counseling
• Anger management
• Cognitive behavioral therapy
• Brief intervention
• Relapse prevention
• Contingency management/motivational incentives
• Motivational interviewing

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Testing

• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening
• Drug and alcohol oral fluid testing

Type of Opioid Treatment

• Buprenorphine maintenance
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Prescribes buprenorphine
• Relapse prevention with naltrexone

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity

Hospitals

• General Hospital (including VA hospital)

Assessment/Pre-treatment

• Screening for tobacco use
• Comprehensive mental health assessment
• Outreach to persons in the community
• Screening for mental disorders
• Comprehensive substance use assessment
• Interim services for clients
• Screening for substance use

Gender Accepted

• Female
• Male

Facility Vaping Policy

• Vaping not permitted

Pharmacotherapies

• Naltrexone (extended-release, injectable)
• Buprenorphine with naloxone
• Non-nicotine smoking/tobacco cessation
• Nicotine replacement
• Medication for mental disorders
• Naltrexone (oral)
• Buprenorphine (extended-release, injectable)
• Disulfiram
• Acamprosate (Campral®)

External Opioid Medications Source

• In-network prescribing entity

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)
• Payment assistance (check with facility for details)

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

License/Certification/Accreditation

• The Joint Commission
• State Substance use treatment agency
• State mental health department
• State department of health

Payment/Insurance/Funding Accepted

• Federal, or any government funding for substance use treatment programs
• Private health insurance
• Medicare
• State-financed health insurance plan other than Medicaid
• Medicaid
• Cash or self-payment
• Federal military insurance (e.g., TRICARE)

Other Services

• Treatment for other addiction disorder

Facility Smoking Policy

• Smoking not permitted

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Language Services

• Sign language services for the deaf and hard of hearing

Special Programs/Groups Offered

• Adult women
• Adult men